75 115

Cited 31 times in

Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine

DC FieldValueLanguage
dc.contributor.author노성훈-
dc.contributor.author정재호-
dc.contributor.author최윤영-
dc.date.accessioned2018-03-26T16:53:01Z-
dc.date.available2018-03-26T16:53:01Z-
dc.date.issued2015-
dc.identifier.issn0513-5796-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/156916-
dc.description.abstractGastric cancer imposes a global health burden. Although multimodal therapies have proven to benefit patients with advanced diseases after curative surgery, the prognosis of most advanced cancer patients still needs to be improved. Surgical extirpation is the mainstay of gastric cancer treatment. Indeed, without curative surgery, variations and combinations of chemotherapy and/or radiation cannot bring clinically meaningful success. Centered around D2 surgery, adjuvant and peri-operative multimodal therapies have improved survival in a certain group of gastric cancer patients. Moving toward a personalized cancer therapy era, molecular targeted strategies have been tested in clinical trials for gastric cancer. With some success and failures, we have learned valuable lessons regarding the biology of gastric cancer and the clinical relevance of biological therapies in addition to conventional treatments. Future treatment of gastric cancer will be shifted to molecularly tailored and genome information-based personalized therapy. Collaboration across disciplines and actively adopting emerging anti-cancer strategies, along with in-depth understanding of molecular and genetic underpinnings of tumor development and progression, are imperative to realizing personalized therapy for gastric cancer. Although many challenges remain to be overcome, we envision that the era of precision cancer medicine for gastric cancer has already arrived and anticipate that current knowledge and discoveries will be transformed into near-future clinical practice for managing gastric cancer patients.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherYonsei University-
dc.relation.isPartOfYONSEI MEDICAL JOURNAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHCombined Modality Therapy-
dc.subject.MESHFemale-
dc.subject.MESHGastrectomy-
dc.subject.MESHHumans-
dc.subject.MESHPrecision Medicine*-
dc.subject.MESHPrognosis-
dc.subject.MESHStomach Neoplasms/surgery*-
dc.titleEvolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Surgery-
dc.contributor.googleauthorYoon Young Choi-
dc.contributor.googleauthorSung Hoon Noh-
dc.contributor.googleauthorJae-Ho Cheong-
dc.identifier.doi10.3349/ymj.2015.56.5.1177-
dc.contributor.localIdA01281-
dc.contributor.localIdA03717-
dc.contributor.localIdA04138-
dc.relation.journalcodeJ02813-
dc.identifier.eissn1976-2437-
dc.identifier.pmid26256958-
dc.subject.keywordGastric cancer-
dc.subject.keywordprecision medicine-
dc.subject.keywordtreatment-
dc.contributor.alternativeNameNoh, Sung Hoon-
dc.contributor.alternativeNameCheong, Jae Ho-
dc.contributor.alternativeNameChoi, Yoon Young-
dc.contributor.affiliatedAuthorNoh, Sung Hoon-
dc.contributor.affiliatedAuthorCheong, Jae Ho-
dc.contributor.affiliatedAuthorChoi, Yoon Young-
dc.citation.volume56-
dc.citation.number5-
dc.citation.startPage1177-
dc.citation.endPage1185-
dc.identifier.bibliographicCitationYONSEI MEDICAL JOURNAL, Vol.56(5) : 1177-1185, 2015-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.